To exploit tumor metabolism, researchers developed a glioma-targeted system (M@HLPC) incorporating lactate oxidase (LOX), hemoglobin–O2 (Hb–O2), CPPO, and chlorin e6 (Ce6), cloaked with U251 glioma cell membranes. This evidence concerns the gene LOX and central nervous system cancer.